Literature DB >> 30661628

HIQA's Perspective on the Challenges Posed by Evaluations of Screening Programs: A Reply.

James F O'Mahony1.   

Abstract

Mesh：

Year:  2018        PMID： 30661628     DOI： 10.1016/j.jval.2018.06.021

Source DB:  PubMed          Journal:  Value Health        ISSN： 1098-3015            Impact factor:   5.725


× No keyword cloud information.
  1 in total

1.  Beneluxa: What are the Prospects for Collective Bargaining on Pharmaceutical Prices Given Diverse Health Technology Assessment Processes?

Authors:  James F O'Mahony
Journal:  Pharmacoeconomics       Date:  2019-05       Impact factor: 4.981
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.